Oculopharyngeal muscular dystrophy

Oculopharyngeal muscular dystrophy
Oculopharyngeal muscular dystrophy
Classification and external resources
ICD-10 G71.0
ICD-9 359.1
OMIM 164300
DiseasesDB 29869
MeSH D039141

Oculopharyngeal muscular dystrophy (OPMD) is an autosomal dominant[1] neuromuscular disease which appears in early middle age (sixth decade).[2] OPMD is an example of a trinucleotide repeat disorder caused by expanding (GCN)10 to (GCN)11-17 at the 5' end of the coding region for PABPN1. This expands the polyalanine tract at the N-terminus of PABPN1 from 10 to 11-17 alanines.[3][4]

Contents

Signs and symptoms

Progressive ptosis (drooping of eyelids)and weakness of the extraocular muscles is the initial clinical finding which continues until paralysis of all eye movements occurs; however, pupillary reactions remain unaffected. Dysphagia (difficulty swallowing), facial weakness and proximal limb weakness develops later on in the disease. [2]

Diagnosis

A muscle biopsy reveals abnormal vacuoles within muscle fibres. A distinction between OPMD and myasthenia gravis or mitochondrial myopathy must be made. The absence of family history and the fluctuation of symptoms in myasthenia gravis usually distinguish the two conditions.[5]

Epidemiology

The disease is frequently seen in French Canadians, with a prevalence 1:1000. A 1997 study from Israel showed the second largest cluster of known individuals are of Bukhara Jews from Uzbekistan, with a calculated minimal prevalence of 1:600. [6] The disease is uncommon in Asian populations. [7]

Treatment

Treatment is supportive to the patient with death eventually occurring from infections. Difficulty with swallowing may result in nasogastric feeding.[3] Some surgeries are available that can reduce ptosis and dysphagia.[8]

References

  1. ^ Davies Je, B. Z. (February 2006). "Oculopharyngeal muscular dystrophy: Potential therapies for an aggregate-associated disorder". The International Journal of Biochemistry & Cell Biology 38 (9): 1457–1462. doi:10.1016/j.biocel.2006.01.016. PMID 16530457.  edit
  2. ^ a b Brais B, Bouchard JP, Xie YG, et al. (Feb 1998). "Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy". Nat. Genet. 18 (2): 164–7. doi:10.1038/ng0298-164. PMID 9462747. 
  3. ^ a b Lindsay, Kenneth W; Ian Bone, Robin Callander, J. van Gijn (1991). Neurology and Neurosurgery Illustrated. United States: Churchill Livingstone. pp. 453. ISBN 0-443-04345-0. 
  4. ^ Goh KJ, Wong KT, Nishino I, Minami N, Nonaka I (2005). "Oculopharyngeal muscular dystrophy with PABPN1 mutation in a Chinese Malaysian woman". Neuromuscul. Disord. 15 (3): 262–4. doi:10.1016/j.nmd.2004.10.016. PMID 15725589. http://linkinghub.elsevier.com/retrieve/pii/S0960-8966(04)00308-6. 
  5. ^ http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=opmd
  6. ^ http://www.ncbi.nlm.nih.gov/pubmed/9392014
  7. ^ http://memo.cgu.edu.tw/cgmj/3301/330105.pdf
  8. ^ Brais, B (2009 Jan). "Oculopharyngeal muscular dystrophy: a polyalanine myopathy.". Current neurology and neuroscience reports 9 (1): 76–82. PMID 19080757. 

External links


GeneReviews Washington State University, funded by NIH


Wikimedia Foundation. 2010.

Игры ⚽ Нужна курсовая?

Look at other dictionaries:

  • oculopharyngeal muscular dystrophy — noun a form of muscular dystrophy that usually begins between early adulthood and middle age and first affects muscles of the eyelid and throat; progresses slowly with swallowing problems common as the disease progresses; inheritance is autosomal …   Useful english dictionary

  • Muscular dystrophy — Classification and external resources ICD 10 G71.0 ICD 9 359.0 …   Wikipedia

  • muscular dystrophy — noun any of several hereditary diseases of the muscular system characterized by weakness and wasting of skeletal muscles (Freq. 2) • Syn: ↑dystrophy • Hypernyms: ↑genetic disease, ↑genetic disorder, ↑genetic abnormality, ↑genetic defect …   Useful english dictionary

  • Muscular Dystrophy Canada — (MDC) (French: Dystrophie musculaire Canada) is a non profit organization that strives to find a cure for neuromuscular disorders. Founded in 1954 as Muscular Dystrophy Association of Canada, volunteers and staff nation wide have helped to… …   Wikipedia

  • Muscular Dystrophy Community Assistance Research and Education Amendments of 2001 — MDCC redirects here. It is also the roman numeral for 1700. The Muscular Dystrophy Community Assistance Research and Education Amendments of 2001 ( MD CARE Act , Pub.L. 107 84, H.R. 717, 115 Stat. 823, enacted December 18, 2001)… …   Wikipedia

  • Muscular Dystrophy Association — The Muscular Dystrophy Association (MDA) is an American organization which combats muscular dystrophy and diseases of the nervous system and muscular system in general by funding research, providing medical and community services, and educating… …   Wikipedia

  • Muscular dystrophy, oculopharyngeal — A form of muscular dystrophy that begins in the muscles of the eyes and throat. It usually appears between the ages of 40 and 60, and progresses slowly. It is caused by an error on chromosome 14, and occurs in both males and females …   Medical dictionary

  • Duchenne muscular dystrophy — Classification and external resources Histopathology of gastrocnemius muscle from patient who died of pseudohypertrophic muscular dystrophy, Duchenne type. Cross section of muscle shows extensive replacement of muscle fibers by adipose cells …   Wikipedia

  • Facioscapulohumeral muscular dystrophy — FSHD redirects here. For other uses, see FSHD (disambiguation). Facioscapulohumeral muscular dystrophy Classification and external resources ICD 10 G71.0 ICD 9 …   Wikipedia

  • Congenital muscular dystrophy — Classification and external resources ICD 10 G71.2 ICD 9 359.0 …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”